Dr. Patricia Ann Young, MD

Dr. Young practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Young's NPI, 1285957589, was assigned on March 2, 2010. Dr. Young graduated from Drexel University College Of Medicine in 2009. Dr. Young holds California license A115400.

Dr. Young's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Young's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Young is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Young to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Young is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Young's licenses on file in 2 states: California and New Jersey.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Young treats.

CMS data shows 1,444 Medicare services from Dr. Young across 17 procedure codes in 2024, for 226 Medicare patients. Medicare paid $74,973 for them.

CMS counts 226 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 100 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 66, with 48% women.

In 2024, Dr. Young wrote 554 Medicare Part D claims for 76 patients. 69% of them were for generic drugs. CMS names the drug for 358 of them, across 17 drugs with 11 or more claims each, at $1,671,665 in total drug cost. In 2023, CMS named 180 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Young for performance year 2024, reported as part of a group. Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Young as offering telehealth.

Dmand AI links 2 papers to Dr. Young. Dr. Young's most frequent co-authors are Satiro Nakamura De Oliveira, MD, Richard Joseph Pietras, MD and John Matthew Timmerman, MD.

Dmand AI links Dr. Young to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 15 general payments to Dr. Young from 8 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 58% of the total. Merck Sharp & Dohme Corporation paid the most, $902.

Dr. Young graduated from Drexel University College Of Medicine in 2009.

Dr. Young is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.